ATE308621T1 - Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer - Google Patents

Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer

Info

Publication number
ATE308621T1
ATE308621T1 AT00401568T AT00401568T ATE308621T1 AT E308621 T1 ATE308621 T1 AT E308621T1 AT 00401568 T AT00401568 T AT 00401568T AT 00401568 T AT00401568 T AT 00401568T AT E308621 T1 ATE308621 T1 AT E308621T1
Authority
AT
Austria
Prior art keywords
production
gene transfer
retroviral constructs
replicating
replicating retroviral
Prior art date
Application number
AT00401568T
Other languages
English (en)
Inventor
David Klatzmann
Arnaud Morel
Georg Holzer
Jean-Loup Salzmann
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of ATE308621T1 publication Critical patent/ATE308621T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT00401568T 1999-06-09 2000-06-05 Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer ATE308621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99401391A EP1059357A1 (de) 1999-06-09 1999-06-09 Replizierende oder 'semi-replizierende' retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer

Publications (1)

Publication Number Publication Date
ATE308621T1 true ATE308621T1 (de) 2005-11-15

Family

ID=8242006

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00401568T ATE308621T1 (de) 1999-06-09 2000-06-05 Replizierende retrovirale konstrukte, ihre herstellung und verwendungen für den gentransfer

Country Status (6)

Country Link
US (1) US6485965B1 (de)
EP (1) EP1059357A1 (de)
JP (1) JP2001000195A (de)
AT (1) ATE308621T1 (de)
CA (1) CA2307933A1 (de)
DE (1) DE60023600T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1932426A1 (de) * 1998-10-01 2008-06-18 University of Southern California Genlieferungssystem und Verwendungsverfahren
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
DK1412493T3 (da) 2001-08-02 2012-01-09 Inst Clayton De La Rech Fremgangsmåder og sammensætninger der angår forbedrede lentiviral-vektor.-produktionsystemer
GB0220467D0 (en) 2002-09-03 2002-10-09 Oxford Biomedica Ltd Composition
JP2007505130A (ja) * 2003-09-09 2007-03-08 バイレクシス コーポレイション ヒトにおいてｈｉｖに対する免疫応答を生成するための、レンチウイルスベクターベースのアプローチ
DE602005023426D1 (de) 2004-03-25 2010-10-21 California Inst Of Techn Hybridisierungskettenreaktion
AU2005309485A1 (en) * 2004-11-24 2006-06-01 Nanovector Limited Viral vectors
US7727721B2 (en) * 2005-03-08 2010-06-01 California Institute Of Technology Hybridization chain reaction amplification for in situ imaging
EP1931806B1 (de) 2005-10-07 2011-10-05 California Institute Of Technology Pkr-aktivierung mittels hybridisierungskettenreaktion
WO2008106658A2 (en) * 2007-03-01 2008-09-04 California Institute Of Technology TRIGGERED RNAi
EP2155770B1 (de) 2007-05-16 2013-10-16 California Institute of Technology Vielseitiges nukleinsäure-haarnadel-motiv zur programmierung biomolekularer selbstanordnungspfade
US8497364B2 (en) * 2008-02-27 2013-07-30 California Institute Of Technology Triggered RNAi
US20100021904A1 (en) * 2008-05-21 2010-01-28 Pierce Niles A Shielded cross-linking probes
US8241854B2 (en) 2008-05-22 2012-08-14 California Institute Of Technology Triggered RNAi
US20100021901A1 (en) * 2008-05-22 2010-01-28 Peng Yin Compositions and methods for detecting analytes
US8658780B2 (en) 2010-05-18 2014-02-25 California Institute Of Technology Triggered covalent probes for imaging and silencing genetic expression
US9834439B2 (en) 2010-07-20 2017-12-05 California Institute Of Technology Biomolecular self-assembly
US8877438B2 (en) 2010-07-20 2014-11-04 California Institute Of Technology Self-assembled polynucleotide structure
US8962241B2 (en) 2010-07-20 2015-02-24 California Institute Of Technology Triggered molecular geometry based bioimaging probes
CN104884627A (zh) 2012-10-25 2015-09-02 托卡根公司 具有小型启动子盒的逆转录病毒载体
US9856472B2 (en) 2013-07-01 2018-01-02 California Institute Of Technology Small conditional RNAs
EP3943613A1 (de) 2016-07-05 2022-01-26 California Institute of Technology Hybridisierungskettenreaktion mit fraktioniertem initiator
WO2018044939A1 (en) 2016-08-30 2018-03-08 California Institute Of Technology Immunohistochemistry via hybridization chain reaction
EP3595561B1 (de) 2017-03-13 2021-12-01 Covidien LP Elektrochirurgisches instrument mit auslösungsgesteuerter schneidfunktion
EP4284925A1 (de) 2021-01-26 2023-12-06 California Institute of Technology Allosterische bedingte guide-rnas zur zellselektiven regulierung von crispr/cas
CN116478939B (zh) * 2023-06-20 2023-09-08 天津瑞普生物技术股份有限公司 表达禽脑脊髓炎病毒p1和3c基因的重组禽痘病毒及其构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834256A (en) * 1993-06-11 1998-11-10 Cell Genesys, Inc. Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
FR2751345B1 (fr) * 1996-07-16 1998-09-18 Univ Paris Curie Lignees d'encapsidation hautement productrices
US5869035A (en) 1996-11-13 1999-02-09 Human Gene Therapy Research Institute Methods and compositions for inducing complement destruction of tissue

Also Published As

Publication number Publication date
CA2307933A1 (en) 2000-12-09
EP1059357A1 (de) 2000-12-13
JP2001000195A (ja) 2001-01-09
DE60023600T2 (de) 2006-08-10
US6485965B1 (en) 2002-11-26
DE60023600D1 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
DE60023600D1 (de) Replizierende retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer
WO2003093449A3 (en) Methods for delivery of nucleic acids
ATE367448T1 (de) Zusammensetzung enthaltend nukleinsäuren und kationische polymere, zubereitung und verwendung
ATE284383T1 (de) Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen
WO2003020949A3 (en) Targeted nucleic acid constructs and uses related thereto
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
ATE312190T1 (de) Nukleinsaeure enthaltende zusammensetzungen, herstellung und verwendung
ATE300613T1 (de) Menschliche, für zyklische nukleotide spezifische phosphodiesterase
ATE313642T1 (de) Nukleinsäure enthaltende zusammensetzung, herstellung und verwendung
NZ289720A (en) Nucleic acids coding for a telomerase, a ribonucleoprotein enzyme involved in telomere synthesis
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
DE69906977D1 (de) In liposomen verkapselte nukleinsäurekomplexe
HK1156069A1 (zh) 用作體外和體內 轉染與基因治療載體的完整微細胞
DE60042821D1 (de) 6-alkenyl, 6-alkynyl und 6-epoxy- epothilon-derivate. verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zusammensetzungen
CY1105416T1 (el) Μεθοδος παρασκευης πολυαλκυλενιμινων που φερουν λειτουργικη ομαδα, συνθεσεις που τις πepιεχουν και οι χρησεις τους
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
ZA971158B (en) Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs.
DK1175489T3 (da) Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider
ATE346859T1 (de) Zusammensetzung zum zellspezifischen transfer von wirkstoffen
HUP0004577A1 (hu) Kationos nukleinsav transzfekciós ágensek új csoportja
CA2441535A1 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
ATE355385T1 (de) Herstellung von rekombinanten adenoviren und von adenovirus-genbanken
DE59813469D1 (de) Linker-nucleosid, seine herstellung und verwendung
HUP0200345A2 (hu) Új nukleinsav-transzferáló ágensek, ezeket tartalmazó készítmények és alkalmazásuk
EP1094115A4 (de) (-)-strang rns virusvektor für nervenzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties